ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
153 hedge funds and large institutions have $858M invested in Achillion Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 46 increasing their positions, 56 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
+1
Holders Change %
+0.66%
% of All Funds
4.08%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
26
Increased
46
Reduced
56
Closed
23
Calls
$14.1M
Puts
$3.62M
Net Calls
+$10.5M
Net Calls Change
-$14.2M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$14.4M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$6.26M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.67M |
| 4 |
RI
RTW Investments
New York
|
+$4.4M |
| 5 |
GAM
Gotham Asset Management
New York
|
+$4.28M |
